With new leadership, Translational Research Council advances cancer discoveries
The Translational Research Council aims to efficiently move cancer research discoveries from the lab to the clinic to benefit patients.
The Translational Research Council aims to efficiently move cancer research discoveries from the lab to the clinic to benefit patients.
The projects have the potential to significantly advance the understanding of the molecular basis of cancer and its prevention and treatment.
The Phase 1 clinical trial is expected to enroll up to 18 children between 4 and 18 years old with pediatric high-grade gliomas.
Innovative research at the UF Health Cancer Center is making a meaningful difference for those affected by cancer.
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
In a CGTlive interview, John Ligon, M.D., discussed establishing a roadmap for CAR-T fertility research.
The project will study the impact of race and ethnicity on immunotherapy outcomes in children and adolescent young adult patients with cancer.